It is called Orforglipron and acts on the GLP-1 receptors. Study involved more than 3,000 people.
A new compressed It appears to be a method promising For those who want to stop being obese: 20% of the weight of the person.
It’s called orforglipron, It will be to be taken daily and acts in GLP-1 receivers (such as injections for weight loss like Mounjaro and Wegovy).
It involved more than 3,000 obese adults without diabetes. 18,4% of those who received the highest dose managed to reduce 20% or more of the weight throughout 72 weeks.
Who took 6 mg per day managed to lower, on average, 7,5% In weight; Who took 36 mg a day lost 11,2%. More than half of participants who took the highest dose reduced at least 10% of the weight.
They were also registered enhancement In blood pressure, waist circumference and LDL cholesterol levels. There was side effects but all light or moderate – especially gastrointestinal problems, details a.
“A daily tablet can allow more people to have access to obesity therapies, especially those who do not have access to injections or have high costs,” explains Sean Wharton, study coordinator.
Researchers argue that, although they do not achieve such effective results as some injections, the tablet is more simple to use, more practical, more cheap.
Orforglipron has not yet been approved by regulatory agencies. But those responsible already foresee a “Search substantial” as soon as the tablet begins to be marketed.
Obesity is a problem that affects more than 1 billion people, according to the World Health Organization. It is almost 15% of the population.
